India's Pharmaceutical Exports

Country Profile

Sweden

Sweden is a growing market for Indian pharmaceuticals — $56.2M in FY 2025–26, with 3.9× growth over the past decade. Medicines accounts for 75% of shipments, with vaccines contributing $41K. The compound annual growth rate since FY2015 stands at 13.2%.

🇸🇪 $56.2M · 3.9× growth since FY2015 · 13.2% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$56.2M
Exports FY2025–26 DGCIS
3.9×
Growth FY2015→2026
13.2%
CAGR FY2015→2026
75%
Medicines Share
5
Product Categories Supplied
Sweden is a growing market for Indian pharmaceuticals — $56.2M in FY 2025–26, with 3.9× growth over the past decade. Medicines accounts for 75% of shipments, with vaccines contributing $41K. The compound annual growth rate since FY2015 stands at 13.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $42.3M (75.2%) Medicine Ingredients $5.22M (9.3%) Traditional & Herbal $5.02M (8.9%) Surgical & Hospital Supplies $3.67M (6.5%) Vaccines $41K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Sweden in the RBI overseas direct investment dataset (2011–2026).